文献速递食管与纵隔外科

年龄对局部晚期食管癌手术结局的影响

Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer.
PubMed 文献 · Ann Thorac Surg · 2020-08-24

基于美国国家癌症数据库2004至2015年数据,纳入17,495例临床II-III期食管腺癌患者,比较手术与根治性放化疗的生存差异。食管切除术后生存随年龄增长而恶化,73岁后显著下降;但在多数年龄组(包括80岁以上)手术生存优于放化疗。

要点

  • 食管切除术后生存随年龄增长而恶化,73岁后下降更显著。
  • 多数年龄组(包括80岁以上)手术生存优于根治性放化疗。
  • 能耐受手术者无论年龄均可考虑食管切除术而非放化疗。

核心结论

  • 局部晚期食管癌食管切除术后生存随年龄增长而恶化。
  • 在多数年龄组包括80岁以上患者中,食管切除术较根治性放化疗与生存改善相关。
  • 能耐受手术的患者无论年龄均可考虑食管切除术而非放化疗。

研究设计与样本

  • 回顾性全国数据库分析,使用美国国家癌症数据库2004至2015年数据。
  • 纳入临床II至III期食管腺癌接受手术或根治性放化疗的患者,共17,495例。
  • 采用限制性立方样条分析年龄与食管切除术后生存的关系,并用最大选择秩统计量确定生存恶化的年龄。
  • 使用含年龄与治疗交互项的Cox比例风险模型比较总生存。

主要发现

  • 17,495例中11,680例接受食管切除术,5,815例接受放化疗。
  • 食管切除术后生存随年龄增长而恶化,73岁后显著下降:73岁后每增一岁HR=1.05(95%CI 1.04-1.06),73岁前每增一岁HR=1.01(95%CI 1.00-1.01),均P<.001。
  • 随年龄增长,放化疗使用较手术 increasingly 增多。
  • 年龄与治疗交互作用显著,交互图显示多数年龄组包括80岁以上患者手术较放化疗有生存获益。

临床怎么用

  • 对于能耐受手术的局部晚期食管腺癌患者,不应仅因年龄大而排除食管切除术。
  • 80岁以上患者若可耐受手术,食管切除术仍可能较根治性放化疗带来生存获益。
  • 年龄增长与术后生存恶化相关,73岁后风险增加更明显,术前评估需综合考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Older patients are often considered high-risk surgical candidates for locally advanced esophageal cancer, and the benefit of surgery in this population is unclear. This national analysis examines the effect of age on esophagectomy outcomes and compares surgery versus chemoradiation in older patients. METHODS: The National Cancer Database was used to identify patients with clinical stage II to III esophageal adenocarcinoma undergoing surgery or definitive chemoradiation between 2004 and 2015. Restricted cubic splines were used to examine the relationship between age and survival after esophagectomy, and maximally selected rank statistics were used to identify an age at which survival worsened. We used Cox proportional hazard models including an interaction term between age and treatment to compare overall survival, as well as survival of patients receiving esophagectomy versus definitive chemoradiation. RESULTS: Of 17,495 patients, 11,680 underwent esophagectomy and 5815 received chemoradiation. Survival after esophagectomy worsened with increasing age and decreased considerably after age 73 (hazard ratio = 1.05, 95% confidence interval, 1.04-1.06, per increasing year after 73 versus hazard ratio = 1.01, 95% confidence interval, 1.00-1.01, per increasing year to 73; both P < .001). Chemoradiation was increasingly used over surgery as age increased. The interaction between age and treatment was significant, and a graph of this interaction demonstrated a survival benefit for surgery over chemoradiation at most ages, including octogenarians. CONCLUSIONS: Survival worsens with age after esophagectomy for locally advanced esophageal cancer. However, esophagectomy is associated with improved survival compared with definitive chemoradiation at most ages, including octogenarians. Esophagectomy may be considered over chemoradiation for patients who can tolerate surgery regardless of age.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Farrow NE, Raman V, Jawitz OK, et al. Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer. Ann Thorac Surg. 2020. PMID: 32853569. doi:10.1016/j.athoracsur.2020.06.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。